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Ascaris suum is known to cause ascariasis of both pigs and humans.  
Ascariasis is associated with a reduced control of intracellular pathogens and 
decreased vaccine efficacy. All-trans retinoic acid (ATRA), an active metabolite of 
Vitamin A (VA), is known to mediate a diverse array of physiological and biological 
processes including immune and inflammatory responses. The phenotype of alveolar 
macrophages (AM), the most abundant cell in the lung, has not been critically 
examined during chronic infection with A. suum nor has the effect of administration 
of dietary ATRA alone or during infection. This combination of treatments is likely 
common in underdeveloped regions where infection with Ascaris is prevalent and 
public health initiatives to control nutrient deficiencies often include VA 
supplementation. In this study we showed that a low dose and repeated “trickle” 
infection with A. suum alone and with ATRA administration altered the AM cell 
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CHAPTER 1: INTRODUCTION 
 
1.1 Ascaris suum 
1.1.1 The parasite 
 Parasitic worms (helminths) infect an estimated 2.5 billion people living in the 
developing world with over 500 million people being infected with at least two 
species [1]. The most common intestinal parasite in humans is an extracellular 
gastrointestinal nematode, Ascaris lumbriocoides, that has a high prevalence among 
children <12 years of age and is associated with malnutrition, disease, and poor 
growth and cognition. [1-2]. Infection with A. lumbriocoides is most common in 
tropical and sub-tropical countries, but it also affects an estimated 4 million people 
per year in the United States [3]. Because infection depends largely on poor 
sanitation, it has the potential to be controlled by health education and better hygienic 
practices; although domestic animals such as pigs and even chickens can also act as 
transport/paratenic hosts for Ascaris eggs [2].  
 Ascaris suum, a closely related large roundworm species, is known to cause 
ascariasis of both pigs and humans. Infective A. suum eggs from pigs have the 
potential to be transmitted to humans through fecal contamination of soil thus posing 
a human health problem given that >50% of all pigs raised for human consumption 
are infected [4]. Ascaris suum is the most common helminth parasite in modern swine 
operations including confinement facilities that fail to control parasite exposure [5]. 
Infections can cause the producer major economic losses by decreased feed 




value, and condemnation of livers [6]. Further economic losses are incurred by 
producers due to the nature of the immune response to A. suum. Pigs infected with A. 
suum exhibit an altered immune response skewed to protect against extracellular 
parasites which leads to diminished vaccine efficacy and a reduced control of 
intracellular pathogens [7-9]. Vaccination is one of the most cost effective practices 
swine producers can implore to benefit the health, growth, and welfare of their 
livestock. Likewise, vaccination is the most cost effective and efficient practice to 
prevent human disease. Several animal models to test vaccination efficacy have 
shown the ability of chronic helminth infections to affect successful vaccination 
outcomes [9].  For example, A. suum infection resulted in higher mean percentage of 
lung pathology, a skewed Th2 response in the lung and draining lymph nodes, and a 
reduction in the percentage of pigs that sero-converted by 25% in pigs vaccinated 
against Mycoplasma hyopneumoniae [10]. 
1.1.2 Life cycle of Ascaris suum 
 Ascaris suum has an intricate life cycle that involves the migration through 
multiple host organ systems (Fig. 1). Infection is initiated by ingestion of eggs 
containing infective larvae that have embryonated in the environment for a minimum 
of 10-14 days at 30°C [1]. As the ingested egg comes into contact with bile acids, the 
second (L2) or third stage larva (L3) is released from the egg casing [1]. Between 6-8 
hours after infection (HAI) newly hatched larvae burrow through the ceacum and 
proximal colon and into the liver where between 10 and 36 HAI they develop into 






FIGURE 1. Life cycle of Ascaris suum.  Migration through host organ systems and 





accumulating in the lungs [11]. Late L3 penetrate into the alveoli where they are 
coughed up into the trachea, swallowed, and migrate into the small intestine. [1,11]. 
At 10 DAI, the larvae arrive in the jejunum where they molt to fourth stage (L4), and 
23-25 DAI larvae mature into fifth stage (L5) or young adult [11]. By 6 to 8 weeks 
after infection adult female ascarids begin to produce thousands of eggs daily, which 
pass out of the host in the feces [12]. Adult ascarids inhabit the lumen of the jejunum 
and feed on the intestinal contents robbing the host of nutrients [1].  In both humans 
and pigs, migrating larvae produce liver lesions (milk spot) and eosinophilic 
pneumonitis in the lungs; they may also migrate into unusual sites such as the bile 
duct or peritoneum where they have the potential to cause acute and life threatening 
disease [1,13].  
1.1.3 Immune response induced by Ascaris suum  
Infection Characteristics 
 In both humans and pigs the immune response to A. suum is characterized by 
a classical helminth induced Th2 response associated with elevated levels of IL-4, IL-
5, and IL-13 cytokine production and gene expression, elevated levels of circulating 
and cell bound immunoglobulin E (IgE), eosinophilia, and intestinal mucosal mast 
cell hyperplasia [4,14]. The L4 induce a partial self-clearing response from the 
jejunum between 14 and 21 DAI that is associated with a localized mast cell-
dependent immediate type hypersensitivity response to A. suum antigens [4,15-16]. In 
both humans and pigs eosinophilic pneumonitis and an immediate type I 
hypersensitivity is induced by L3 that migrate through the alveolar spaces of the lung 




Protective Immune Response to Ascaris suum 
 Ascaris suum infection is more common among young developing piglets than 
among adult pigs, indicating a protective immune response to subsequent parasite 
infections. Further evidence of protective immunity in swine is evident by a reduced 
number of liver milk spots after subsequent re-infection and a reduced recovery of 
larvae from the liver and lungs [18-19]. In pigs immunized with adult worms and then 
treated with anthelmintics prior to reinoculation exhibit a strong protective response 
characterized by peripheral blood eosinophilia and A. suum specific antibody 
secreting cells draining the sites of infection, as well as a reduced recovery of larvae 
from the lungs and small intestine [20]. A similar phenomenon is seen in children 
where a strong correlation between elevated levels of parasite specific IgE antibodies 
and reduced intestinal worm burden supports a similar mechanism of protective 
immunity [21].  
 
1.2 All-trans retinoic acid 
1.2.1 All-trans retinoic acid and Vitamin A 
Sources of Vitamin A 
 All-trans retinoic acid (ATRA), an active metabolite of Vitamin A (VA), is an 
essential vitamin that mediates a diverse array of physiological and biological 
processes including, vision, growth, reproduction, the control of cell growth and 
differentiation as well as immune and inflammatory responses [22]. VA can be found 
in two main forms in food. One form comes from animal sources such as liver, eggs, 




produced forms such as retinyl palimate, that are converted to retinoic acid in the 
small intestine. [22-23]. Another form is from vegetables such as carrots, and leafy 
greens in the form of carotenoids (pro-vitamin A), which converts to retinol then 
retinoic acid [22-23].  
Vitamin A deficiency and immunity  
 VA deficiency is a serious health problem in the developing world associated 
with weakened innate and adaptive immune responses, enhanced susceptibility to 
infection, diseases and developmental defects [24].  Deficiency is estimated to affect 
approximately 127 million preschool children and 7.2 million pregnant women 
worldwide [25]. A close link between VA nutrient status and immune function has 
been known to exist for more than 70 years with early observations of improved 
outcomes during infections with supplemental VA extracts or VA rich food sources in 
malnourished and deficient animals [22]. Further understanding of the mechanism in 
which VA regulates immunity has been possible by the discovery of two families of 
VA nuclear receptors that regulate gene transcription, RA receptor (RAR) and the 
retinoid X receptor (RXR) [22, 26-27]. Homodimers (RXR/RXR) or heterodimers 
(RAR/RXR) are formed by these receptors and are known to regulate over 500 
different genes [24].    
1.2.2 Vitamin A, immune function, and helminth infections 
  Studies in both humans and mice indicate that VA status alters Th1, Th2 and 
T regulatory immune responses [22]. It is proposed that VA deficiency shifts the 
immune response towards a Th1 cell mediated response whereas VA supplementation 




biased the immune response to Th1 while high levels of VA supplementation biased a 
Th2 [29]. For example, in a mouse model of asthma, high VA supplementation was 
associated with an increase in disease severity and pulmonary Th2 responses to 
ovalbumin, while deficiency was associated with decreased disease severity and Th2 
responses [29-30]. Coexistence of malnutrition and parasitism with ascarids have 
been well documented and the health effects associated with VA status and Ascaris 
infections have been studied extensively [31].  Despite frequent coexistence, little is 
known about their biological interactions, the affect on tissue regeneration, and the 
host pulmonary immune response [31]. Ascaris suum infection severely damages host 
tissue during migration causing extensive hemorrhaging and inflammation. One 
theory is that the Th2-type immune response elicited by these parasites may also 
function to promote a wound healing response and regenerate damaged tissue, 
however there is little evidence in its support.  
 
1.3 Macrophages 
1.3.1 Macrophage phenotypes and classifications  
 Macrophages exist in nearly all tissue and have a diverse functional repertoire 
including host defense, homeostasis, immune regulation, and wound repair [32].  
They are highly susceptible to changes in their microenvironment and display highly 
plastic activation states able to rapidly change and adapt [33]. The ability of 
macrophages to change according to their environment gives rise to different cell 
populations with distinct functions. Several phenotypes or classifications of 




of macrophage activation lies within two main categories, Classically Activated 
Macrophages (CAMs) and Alternatively Activated Macrophages (AAMs). A third 
category of macrophage activation worth mentioning, although our understanding is 
limit, is Regulatory Macrophages (RMs) [34].  
Classically Activated Macrophages(CAM) 
 Priming with IFN-γ  induces the differentiation of CAMs. IFN-γ is a cytokine 
that is produced by both innate (NK cells) and adaptive (Th1 cells) immune cells. 
These cells exhibit enhanced microbicidal activity, increased superoxide anion and 
nitric oxide production, and secrete pro-inflammatory cytokines such as TNFα, IL-6, 
IL-1, and IL-12. Classical activation is important for host defense, especially against 
intracellular pathogens. However, activation of these cells can cause extensive 
damage to the host tissue and their activation must be tightly controlled [32].   
Alternatively Activated Macrophages (AAM) 
 The cytokines IL-4 and/or Il-13, secreted by innate or adaptive immune cells, 
are sufficient to induce differentiation of AAMs. Cells of innate immunity responsible 
for IL-4 and IL-13 induced AAMs include eosinophils, basophils, mast cells, NKT 
cells, and even macrophages themselves [32,35] However, the main source of IL-4 
and IL-13 cytokine production comes from Th2 cells of an adaptive immune 
response. AAMs are characterized by expression of the mannose receptor (CD206), 
reduced pro-inflammatory cytokine production, lower production of superoxide anion 
and nitric oxide production, and inefficient killing of intracellular pathogens [32]. 
AAMs are widely known for their ability to promote wound healing and extracellular 




fibronectin, and by inducing ECM production of nearby fibroblasts [36-37]. In 
addition, alternative activation induces the upregulation of macrophage Arginase I 
(Arg I). Arg 1 converts arginine to ornithine, a precursor of proline and polyamine 
biosynthesis [32]. Like CAMs the dysregulation and uncontrolled activation of 
AAMs can be detrimental to the host. AAMs have been associated with several 
pathologies including tissue fibrosis, severe allergy, and asthma. [32].   
Regulatory Macrophages(RM) 
 RMs are the least studied and were first identified by David Mosser and 
colleagues. They found that in-vitro stimulation of macrophages with a TLR agonist 
in the presence of high density IgG immune complexes lead to the development of a 
population of cells that produced high levels of IL-10. In addition to high IL-10 
production these cells exhibit a repressed production of IL-12. IL-10 is a potent 
inhibitor of inflammation and can inhibit the activity and production of several pro-
inflammatory cytokines, such as IFN-γ, IL-2, and TNF-α. Like AAMs, RMs have a 
reduced ability to kill intracellular parasites, however, unlike AAMs, RMs do not 
appear to contribute to the wound healing processes. Other factors besides immune 
complexes can differentiate RMs, such as prostaglandins, apoptotic cells, IL-10, and 
ligands for G-protein coupled receptors. However, a second stimulus, such as a TLR 
ligand, must be present in order to induce RM activation [32].             
1.3.2 Alveolar Macrophages (AM) 
 As the most abundant cell in the lung and alveolar spaces, AM play a crucial 
role in regulating pulmonary immune responses and inflammation. They serve as the 




particulate debri. Alveolar macrophages have been described as having a unique 
phenotype; one that is comparable to Dendritic cells (DCs) [38]. When cultured in-
vitro they also appear to be significantly better at presenting antigen than 
macrophages from other tissues, however, many studies indicated that they have a 
reduced antigen presentation ability that serves to limit the lung inflammatory 
response [38-41]. Like DCs, AM express CD11c at remarkably high levels. Peritoneal 
macrophages and bone marrow derived macrophages that have been adoptively 
transferred into the lung assume a DC-like phenotype, suggesting the lung 
environment, which is rich in GM-CSF and surfactant proteins, is the reason for the 
unique phenotype of AM [38]. It is believed that AM act as immunosuppressant cells 
that serve to limit T cell-mediated tissue damage of the lung airways [42]. Many 
studies refer or compare them to macrophages that have been alternatively activated 
[40,43]. In fact, AM have high CD206 expression. During infection with the 
gastrointestinal nematode parasite Nippostrongylus brasiliensis, AM from mice up-
regulate several genes associated with alternative activation, such as ARG1, FIZZ1, 
and YM1 [40].   
1.3.3 Macrophages in helminth infections 
 Helminth infections, including Ascaris, induce an immune response that is 
predominately characterized by elevations in Th2 cytokines, IL-4, IL-5, IL-13, IL-9, 
Il-21, and IL-25 [8]. As previously discussed, macrophages activated during Th2 
responses exhibit an alternatively activated phenotype, therefore, macrophages 
involved and observed in a variety of helminth infections are considered to be 




Th1-type inflammation, promote wound healing, and aid in worm expulsion and to 
promote resistance [8]. The mechanisms in which AAMs carry out these host 
protective functions are not well understood. 
1.3.4 Vitamin A and macrophage function 
 Data on VAs role in regulating macrophages function is scarce. However, 
there is some evidence that VA status can influence macrophage immune function. 
One study showed the ability of VA to inhibit mouse macrophage IL-12 production in 
vitro, while another study in VA deficient mice demonstrated increased nitric oxide 
production by mouse peritoneal macrophages after LPS stimulation. These studies 
suggest that VA deficiency causes increased inflammation that is mediated by 
macrophage pro-inflammatory cytokine production. [28,44-45].   
 
1.4 Pig as a model for Ascaris infection 
 A rodent model for Ascaris infection is not practical; they are not natural hosts 
and will not support the development of the late larval and adult stages in the intestine 
[15,46]. Human studies are limited and in most aspects unfeasible and unethical. 
However, using the pig as a model for Ascaris infection has several advantages. Pigs 
are naturally susceptible to helminth infections such as Ascaris and generally have 
more anatomical and physiological similarities to humans than many other animal 
models [15,46].  Detailed analysis of the pig, human, and mouse genomes associated 
with the immune response demonstrated a greater similarity between human and pig 




model, such as limited immunological reagent. Hopefully with the completion of the 
pig genome more effort will be put into this area [15,46]. 
 
1.5 Summary and significance 
 Ascaris infection is a worldwide problem in both human health and in 
agricultural production of swine. Infection by this parasite can lead to malnutrition, 
disease, and poor growth [1]. It is well known that these parasites induce a Th2-like 
immune response in which AAMs play a crucial role in the hosts’ protective immune 
response [14]. Our understanding of how these parasites affect host pulmonary 
immune responses and alveolar macrophage phenotype and function is lacking.  More 
studies in this area should be pursued given the evidence for a reduced vaccine 
efficacy in pigs, as has also been reported in humans [8,10]. Alveolar macrophages 
are the most abundant cell type found in the alveolus of the lung. They serve as the 
first line of defense against invading pathogens and foreign matter making them a key 
player in pulmonary immunity. Alveolar macrophages have multiple functions that 
are critical to host defense, inflammation, tissue repair, and homeostasis. One 
objective of this study is to gain insight into how chronic A. suum infection affects 
and alters AM phenotype, which could shed light on the function of these 
macrophages.  
 A second aim of this study was to observe the effects of VA supplementation, 
in the form of All-trans Retinoic Acid (ATRA), on macrophage phenotype in both A. 
suum infected and uninfected pigs. VA is an essential nutrient and its deficiency is 




disease states in humans. Notably, in the developing world where malnutrition is 
widespread, high dose VA supplementation of children is commonly practiced. Given 
the prevalence of A. suum in these same populations, it could be assumed that a 
majority of children receiving supplemental VA are also co-infected. Currently, little 
is known about the biological and immune interactions between A. suum and VA 
supplementation and how it affects host health. Likewise there is little data on how 
VA may regulate macrophage function.  Therefore, it is important to study how VA 
in the context of A. suum infection affects macrophage phenotype.  This could also be 





CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Animals 
Twelve pigs (derived from boars from a four-way crossbred composite BX 
line [Duroc X maternal Landrace X terminal Landrace X Yorkshire] designed by 
scientists at the USDA ARS US Meat Animal Research Center, Clay Center, NE to 
be genetically similar to genetics in the commercial swine industry at the time they 
were born) between the ages of 16 and 22 weeks were selected for this study. All 
were male pigs, born, weaned, and maintained at the swine facility located at the 
Beltsville Agricultural Research Center. Pigs were kept two per pen in a parasite-free 
sealed concrete flooring facility and were provided unrestricted access to fresh water 
and appropriate feed rations. Diet consisted of a corn-soybean meal formulation 
containing 16% crude protein, vitamins and minerals that exceeded National 
Research Council guidelines [48].  
 
2.2 Experimental Design 
All procedures were supported by protocol#10-012 and approved by the 
Beltsville Area Animal Care and Use Committee. Pigs used in this study were divided 
into four treatment groups with three pigs per group. The treatments consisted of 1) 
ATRA in corn oil, 2) corn oil only (control), 3) A. suum infected and corn oil, and 4) 
A. suum infected and ATRA in corn oil. The inoculation dose for A. suum “trickle” 
infection was predetermined by a trial infection of 50,000 eggs that yielded 




stock preparation of 50,000 eggs/ml was diluted 1:20 and 1ml was given to each pig 
thrice per week from week 0 to 5. The 2,500 infective egg inoculation dose represents 
approximately 50 L3 migrating through the liver per day. Pigs were orally 
administered ATRA in corn oil at 0.1 mg/kg of body weight while control pigs were 
given an equal amount of corn oil. ATRA dose used in this study was selected 
because it is comparable to doses administered to humans and is physiologically 
relevant [4,49]. ATRA and corn oil were administered six times at days -1, +1, +3, 
+24, +26, and +28 from the start of the trickle infection on day 0. Pigs were 
euthanized 35 days into the study via an overdose of Ethasol (Virbac Animal Health, 
Fort Worth, TX, USA).  
 
2.3 Bronchial alveolar lavage   
Bronchial alveolar lavage (BAL) was obtained from the lungs of all pigs. The 
lobes of the excised lung was gravity-filled with 200-250 ml of phosphate-buffered 
saline (PBS), followed by a 30 second massage and draining of the cell suspension 
into 50 ml polypropylene tubes.  
 
2.4 Flow Cytometry 
Cells were isolated from the BAL fluid by washing twice with PBS 
supplemented with 0.5% bovine serum albumin and were resuspended at 10x106 
cells/ml in pig staining buffer (PBS, 2% porcine serum, 1µg/100µl porcine IgG, and 
0.9 mg/ml sodium azide) and incubated for 30 minutes at 4°C to block non-specific 




transferred into wells of a 96-well V-bottom plate, and the appropriate antibody was 
added and incubated at 4°C in the dark for 30 minutes. Cells were washed with 200µl 
PBS twice, and centrifuged at 200 rpm for three minutes. Cells were then fixed with 
200µl 1% Para formaldehyde (PFA). Data was acquired by running samples on a 
Attune™ Acoustic Flow Cytometer using Attune Cytometric software version 1.2 
(Applied Biosystems, Carlsbad, CA, USA) Data obtained were analyzed via Flowjo 
software version 9.3.2 (Tree Star, Inc., Ashland, OR, USA). Percentages were 




The following antibody was purchased from BD Pharmingen (San Jose, CA, 
USA); anti-porcine ITGB1 CD29-PE (552369).  Anti-human ENTPD1 CD39-PE 
(MCA1268PET), anti-pig CD163-FITC (MCA2311F), and anti-porcine CD203a 
SWC9-FITC (MCA1973F) was obtained from AbD Serotec (Raleigh, NC, USA). 
Anti-human PD-L1 CD274-PE (329706), and isotype control rat IgG2b-PE (400636) 
were obtained from Biolegend (San Diego, CA, USA).  Anti-human/mouse TREM-2-
PE was obtained from R&D Systems (Minneapolis, MN, USA).  Anti-porcine CD-
172a SWC3-PE (4525-09), isotype control mouse IgG1-PE (0102-02), isotype control 
mouse IgG2a-PE (0103-09), and isotype control mouse IgG2b-PE (0104-09) were 
obtained from Southern Biotech (Birmingham, AL, USA). Anti-human MRC1 




anti-human/mouse IL-4Receptor-PE (I8426-70B) was obtained from US Biological 




CHAPTER 3: RESULTS 
 
3.1 Bronchial alveolar lavage cell populations 
 The BAL specimens from each pig were stained with monoclonal antibodies 
against porcine macrophages (CD203a/SWC9) and porcine granulocytes 
(CD172/SWC3). SWC9 is a surface antigen expressed specifically by mature 
macrophages [50]. The antigen SWC3 is expressed by granulocytes including, 
eosinophils, basophils, and neutrophils, and macrophages [51].  Gating of live cells 
from pigs from the four treatment groups and assigning quadrants based on isotype 
control staining revealed the presence of three main cellular profiles, SWC3/SWC9 
double negatives, SWC3 single positives, presumed eosinophils, and SWC3/SWC9 
double positives, macrophages (Fig. 2A). Since the SWC3 antigen is expressed on 
several other cell types, a cyto-spin preparation of the BAL cells stained by diff-quick 
confirmed the predominate granulocyte found in the BAL from all pigs were 
eosinophils (data not shown). Lymphocytes were identified according to side scatter 
and forward scatter profiles, the lack of SWC3 and/or SWC9 expression (Fig 2A,B), 
and by cyto-spin preparations and diff-quick staining (data not shown). 
3.1.1 Percentage of SWC3+/SWC9+ alveolar macrophages in BAL fluid 
 To ensure the phenotypic analysis presented in this study includes a relatively 
pure population, AM were gated according to side and forward scatter and the 
percentage of AM was calculated after determining the percentage of double stained 





A.           B. 
 
  
FIGURE 2. Bronchial alveolar lavage cell populations during Ascaris suum 
trickle infection and ATRA treatment. Cells were stained with porcine monoclonal 
antibodies against porcine macrophages (CD203a/SWC9) and porcine granulocytes 
(CD172a/SWC3) and analyzed by flow cytometry. (A) Quadrants were set based on 
isotype control staining. Lower left quadrants: lymphocytes. Upper left quadrants: 
eosinophils. Upper right quadrants: alveolar macrophages. (B) Alveolar macrophages, 




















































































FIGURE 3. Mean Fluorescent Intensity (MFI) and percentage of alveolar 
macrophages co-expressing porcine macrophage marker SWC9 and porcine 
granulocyte marker SWC3. Cells were stained with porcine monoclonal antibodies 
against macrophages (CD203a/SWC9) and porcine granulocytes (CD172a/SWC3) 
and analyzed by flow cytometry. MFI and percentage that co-express SWC3 and 
SWC9 was calculated. Percentages were determined using Flowjo Super-enhanced D-
max Subtraction statistical software. Inlay within graph represents the mean ± SD 
percentage of alveolar macrophages co-expressing SWC3 and SWC9. Bars on graph 






than 95% ± SD pure AM. This gating was used throughout this study to discriminate 
macrophages from other cell populations recovered from the BAL fluid.  
3.1.2 Population dynamics during A. suum trickle infection and ATRA treatment.  
 To investigate the cellular changes induced by recurrent A. suum larvae 
passing through the lungs and the influence of in-vivo ATRA administration, the 
cellular components of the BAL was characterized in all 4 treatment groups 35 days 
after the beginning of the trickle infection and 7 days after the last ATRA 
administration. Flow cytometric analysis showed that SWC3+/SWC9+ AM were the 
dominant cell type found in the BAL fluid of all four treatment groups, however, pigs 
infected with A. suum had significantly (P< 0.05) reduced percentages of AM 
compared to uninfected pigs (Fig. 4).  Uninfected pigs fed ATRA had a lower 
percentage of AM compared to corn oil fed pigs but slightly higher percentages than 
infected pigs; however these differences were not statistically significant as 
determined by ANOVA.  As previously described [52] there was a significant (P< 
0.05) induction of lung SWC3+/SWC9- eosinophils in the BAL of ATRA fed and A. 
suum trickle infected pigs. Infection alone also resulted in an increase in the 
percentage of lung eosinophil; however these results were found to be statistically 
insignificant since one out of the three pigs analyzed had eosinophil percentages 
similar to that of uninfected pigs. The percentage of lymphocytes recovered from the 
BAL was not significantly affected by A. suum infection or infection plus ATRA 
compared to corn oil fed uninfected pigs. However, ATRA alone when compared to 








FIGURE 4. Bronchial alveolar lavage cell population dynamics during A. suum 
trickle infection and ATRA treatment: percentages of cells recovered from the 
BAL of 3 pigs per group.  Cells were stained with porcine monoclonal antibodies 
against macrophages (CD203a/SWC9) and porcine granulocytes (CD172a/SWC3) 
and analyzed by flow cytometry. Percentage of cell populations was determined by 
quadrant. Results are expressed as the mean ± SD from three pigs per group and 
evaluated by one-way ANOVA. Superscripted letter annotation of treatment groups 






lymphocytes but not when compared to infected or infected and ATRA fed pigs (Fig. 
4). 
 
3.2 Altered alveolar macrophage phenotype induced by all-trans retinoic acid and 
Ascaris suum trickle infection.     
 
 Many helminth infections, including Ascaris suum, are known inducers of 
Th2-type immune responses in which AAM play a pivotal role in expulsion of the 
parasite, controlling inflammation, and promoting tissue repair. [53-54]. 
 ATRA is known to mediate a diverse array of biological processes including 
the control of cell growth and differentiation as well as many immune and 
inflammatory responses [22]. In previous observations, (Dawson, unpublished) 
primary explanted AM stimulated in-vitro with ATRA demonstrate a highly polarized 
AAM phenotype characterized by an up-regulation of several cell surface markers 
associated with alternative activation as well as mRNA induction of alternatively 
activated chemokines.  One objective of this study was to determine if in-vivo ATRA 
administration and/or long-term exposure to A. suum alters AM expression of CD206. 
3.2.1 Alveolar macrophages express alternative macrophage activation marker 
CD206. 
 The mannose receptor (CD206) is a well-known marker used to identify the 
alternative activation of macrophages [35] and can be easily measured via flow 
cytometric techniques. To determine if in-vivo ATRA administration alone or in the 
presence of A. suum trickle infection or infection alone had an influence on AM 
CD206 expression, cells recovered from the BAL fluid were stained with anti-human 





macrophages isolated from control corn oil uninfected pigs revealed a constitutive 
expression of CD206 (Fig 5A). CD206 expression was also observed on BAL cells 
from pigs in the three other treatment groups with no significant increase in mean 
fluorescent intensity. The percentage of macrophages expressing CD206 was greater 
than 95% ± SD for all treatment groups (Fig. 5B).  
3.2.2 Ascaris suum infection induces a higher expression of CD163 on alveolar 
macrophages. 
  CD163 is a cystine rich, hemoglobin scavenger receptor expressed 
exclusively on monocytes and macrophages [55]. It scavenges hemoglobin by 
binding and internalizing haptoglobin-hemoglobin complexes with high specificity 
and affinity [56]. Macrophages expressing high levels of CD163 have been identified 
in the resolution phase of inflammation [57], indicating a possible role in regulating 
inflammation and tissue repair.  
 The surface expression of CD163 on AM from the BAL cells of pigs from all 
treatment groups was analyzed to determine if CD163 may have a role in regulating 
inflammation during A. suum infection and could be modulated by administration of 
ATRA in-vivo. CD163 is constitutively expressed on AM of corn oil uninfected pigs 
and is not significantly affected by ATRA administration; however both groups of 
infected pigs, regardless of ATRA treatment status, exhibited significantly (P < 0.01) 
elevated CD163 expression (Fig. 6A and B) ATRA did not significantly affect 
CD163 expression during infection. The percentages of AM expressing CD163 are 










FIGURE 5. Alveolar macrophages express alternative activation marker CD206. 
Cells isolated from the BAL were stained with anti-human CD206, alveolar 
macrophage populations were determined by FSC/SSC gating of live cells and 
analyzed by flow cytometry. (A) Flow cytometry histograms of alveolar macrophage 
CD206 expression in all groups. Isotype control is illustrated in red, CD206 surface 
levels are represented in blue. Profiles are representative of three biological 
replicates. (B) MFI and percentage of gated alveolar macrophage expressing CD206. 
Percentages were determined using Flowjo Super-enhanced D-max Subtraction 
statistical software. Results are expressed as the mean MFI ± SD and mean 
percentage cells expressing CD206 ± SD evaluated by ANOVA.  
ATRA/None

























































FIGURE 6. Alveolar macrophages have a higher expression of CD163 during A. 
suum trickle infection. Cells isolated from the BAL of three pigs per treatment 
group were stained with anti-pig CD163, alveolar macrophage populations were 
determined by FSC/SSC gating of live cells and analyzed by flow cytometry. (A) 
Representative flow cytometry histograms of alveolar macrophage CD163 
expression. Representative isotype control staining is illustrated in red, CD163 
expression for Co/Trickle is in blue, ATRA/Trickle in Green, ATRA/None in black, 
and CO/None in orange. Profiles are representative of three biological replicates. (B) 
MFI and percentage of alveolar macrophage expressing CD163 Results are expressed 
as the mean ± SD evaluated by ANOVA. Percentages were determined using Flowjo 
Super-enhanced D-max Subtraction statistical software. Superscripted letter 
annotation of treatment groups represents the statistical difference between the groups 
scoring P values of <0.01. 
  






















3.2.3 The expression of IL-4R and TREM2 associated with macrophage alternative 
activation are altered during all-trans retinoic acid administration and A. suum trickle 
infection. 
 The signaling pathway induced by the Th2 cytokines, IL-4 and IL-13, are 
dependent on the expression of IL-4 receptors. The functional IL-4 receptor is a 
complex consisting of IL-4Rα chain and the IL-2 gamma common (γc) chain [54]. 
Studies using mice report an increase in macrophages expressing both CD206 and the 
IL-4Rα and also the requirement of the IL-4Rα to induce macrophage alternative 
activation essential for survival during helminth infection [58-59].  
 ATRA treatment in vitro of primary explanted porcine AM and porcine cell 
lines have shown an increase in the IL-4Rα expression indicating a possible 
modulation of it expression by this VA metabolite (Dawson, data unpublished).  In 
the current study the surface expression of the IL-4R was measured to determine if A. 
suum trickle infection or in-vivo administration of ATRA had an effect on its 
expression. IL-4R expression in control corn oil fed pigs was very low and remained 
low in infected pigs regardless of ATRA status, however uninfected pigs fed ATRA 
had higher levels of its expression (Fig. 7A). Uninfected ATRA fed pigs also 
displayed a significantly higher percentage of cells expressing IL-4R, 33.82% ± 
10.89%, compared to the other treatment groups. Although the expression of IL-4R 
on ATRA fed and infected pigs was not significantly elevated above controls, it was 
noted that the percentage of cells expressing IL-4R in infected pigs fed ATRA was 
significantly (P>0.05) higher, 14.76% ± 3.12% compared to approximately 3-5%, 











Marker CO/None CO/Trickle ATRA/None ATRA/Trickle  
 Percent  (mean ± SD) 
IL-4R 3.20%  ± 2.54%A 5.53% ± 2.14%A 33.82%  ± 10.89%B 14.76%  ± 3.12%C 
TREM2 30.97%  ± 7.60%A 51.80%  ± 9.07%B 60.20%  ± 14.31%C 31.17%  ± 5.63%A 
  
FIGURE 7. Surface expression and percentage of cells expressing IL-4R and 
TREM2 on alveolar macrophages increase in ATRA fed pigs. Cells isolated from 
the BAL of three pigs per treatment group were stained with anti-human/mouse IL-
4R or anti-human TREM2 and analyzed by flow cytometry. Representative Flow 
cytometry histograms and MFI graph of alveolar macrophages (A) IL-4R and (B) 
TREM2 expression. Representative isotype control is illustrated in red, measured 
marker expression is represented in blue. Alveolar macrophage expressing IL-4R and 
TREM 2 was determined by FSC/SSC gating of live cells. (C) Percentage of cells 
expressing IL-4R/TREM2. Percentages were determined using Flowjo Super-
enhanced D-max Subtraction statistical software. All results are expressed as the 
mean ± SD evaluated by ANOVA. Superscripted letter annotation of treatment 












































































































 Another receptor expressed by macrophages reported to increase in its 
expression during alternative activation is TREM2 [54]. In mice TREM2 expression 
has been reported on infiltrating thioglycollate elicited peritoneal macrophages and 
tissue resident macrophages in the presence of Th2 cytokines and serves to inhibit 
macrophage cytokine production in response to TLR ligands [60]. TREM2 expression 
was significantly (P>0.05) increased in pigs fed ATRA only and in infected pigs both 
with and without ATRA treatment compared to control corn oil fed pigs; ATRA 
treatment alone had the highest expression of TREM2 (Fig. 7B). ATRA only fed pigs 
also had the highest percentage of cells expressing TREM2, 60.20% ± 14.31%. Corn 
oil fed and infected pigs had the next highest percentage of cells expressing TREM2, 
51.80% ± 9.07%. The percentage of cells expressing TREM2 in both CO/ATRA and 
CO/Trickle pigs was found to be significantly (P<0.05) different from control, 
30.97±7.60%, and ATRA/Trickle pigs, 31.17%±5.63%, (Fig. 7C). 
3.2.4 PDL-1 (CD274) alveolar macrophage expression is altered by Ascaris suum 
infection and in-vivo ATRA administration. 
 A previous experiment by Siracusa et al. involving the infection of mice with 
the parasitic helminth Nippostrongylus brasiliensis showed constitutive expression of 
CD274 by AM that significantly increased in its expression 13 days post-infection. 
[40].   In the current study, the surface expression of CD274 was measured to 
determine if it expression profile was affected by A. suum trickle infection and/or 
administration of ATRA. Cells from the BAL fluid of pigs from all four treatment 
groups were stained with anti-human CD274 (PDL-1) monoclonal antibody. Analysis 
of AM from control corn oil fed pigs revealed a constitutive expression of CD274, 




treated pigs (Fig. 8A).  ATRA alone also significantly increased CD274 expression 
compared to control corn oil fed pigs but had slightly lower expression compared to 
infected pigs. The percentage of cells expressing CD274 did not significantly change 
during infection and/or ATRA administration (Fig 8B). 
3.2.5 Surface phenotype of alveolar macrophages during A. suum infection and in-
vivo administration of ATRA. 
    The surface expression of CD29 and CD39 were also analyzed in this study. 
Alveolar macrophage CD29 expression significantly (P<0.05) decreased during A. 
suum infection in both CO/Trickle and ATRA/Trickle pigs but was found to be 
significantly (P<0.05) increased on AM of pigs only administered ATRA (Fig. 9A) 
Trickle infection greatly reduced the percentages of cells expressing CD29 compared 
to control corn oil and ATRA fed pigs (P<0.01).  Approximately 80% of AM express 
CD29 in control and ATRA pigs compared to 0-5% in infected pigs (Fig. 9C). The 
molecule involved in adenosine metabolism CD39 was significantly (P<0.01) 
affected by ATRA because its expression was elevated only in pigs fed ATRA in the 
absence of infection (Fig. 9B). Likewise the percentage of AM expressing CD39 was 







Marker CO/None CO/Trickle ATRA/None ATRA/Trickle  
 Percent cells  (mean ± SD) 
CD274 80.23%  ± 7.16% 85.80%  ± 4.96% 83.40%  ± 6.70% 88.43%  ± 2.20% 
 
FIGURE 8. Ascaris suum Infection and/or ATRA increase alveolar macrophages 
PDL-1 expression. Cells were isolated from the BAL of three pigs per treatment 
group and stained with anti-human CD274 (PDL-1) and analyzed by flow cytometry. 
Representative flow cytometry histograms and MFI graph of alveolar macrophages 
(A) CD472 expression. Representative isotype control staining is illustrated in red, 
measured marker expression is represented in blue. Alveolar macrophages were 
determined by FSC/SSC gating of live cells. (C) Percentage of cells expressing 
CD274. Percentages were determined using Flowjo Super-enhanced D-max 
Subtraction statistical software. All results are expressed as the mean ± SD evaluated 
by ANOVA. Superscripted uppercase letter annotation of treatment groups represents 
the statistical difference between the groups scoring P values <0.05. 
ATRA/None




















































A.            
   




Marker CO/None CO/Trickle ATRA/None ATRA/Trickle 
 Percent cells  (mean ± SD) 
CD29 76.70% ± 9.36A 0% ± 0 %B 82.57% ± 14.02%A 5.0% ± 8.66%C 
CD39 0.57% ± 0.80%A 0.18% ± 0.16%A  35.73% ± 5.7%B 0.6% ± 0.52%A 
  
FIGURE 9. Surface phenotype of alveolar macrophages. Cells were isolated from 
the BAL of three pigs per treatment group and stained with anti-human CD29 or anti-
human CD39 and analyzed by flow cytometry. Representative Flow cytometry 
histograms and MFI graph of alveolar macrophages (A) CD29, (B) CD39 expression. 
Representative isotype staining is illustrated in red, measured surface molecule 
expression is represented in blue. Alveolar macrophages determined by FSC/SSC 
gating of live cells. (C) Percentage of cells that express the measured surface 
molecule. Percentages were determined using Flowjo Super-enhanced D-max 
Subtraction statistical software. All results are expressed as the mean ± SD evaluated 
by ANOVA. Superscripted uppercase letter annotation of treatment groups represents 
the statistical difference between the groups scoring P values <0.05. 







































































































CHAPTER 4: DISCUSSION 
 The phenotype of alveolar macrophages (AM) during chronic trickle infection 
with A. suum has not been critically examined nor has the effect of administration of 
ATRA in the diet alone or during infection. This combination of treatments is likely 
common in humans from underdeveloped regions where infection with Ascaris is 
prevalent and where public health initiatives to control nutrient deficiencies often 
include supplementation with VA. In this study we showed that a low dose and 
repeated “trickle” infection with A. suum  alone and with ATRA administration 
altered the AM cell surface antigen phenotype. An infective dose of 2,500 eggs was 
given three times per week for five weeks to pigs. Oral administration of ATRA was 
given at six different time points throughout a five-week period to both infected and 
uninfected pigs. Bronchial alveolar lavage (BAL) fluid was collected to obtain an 
enriched and reliable source of AM. The collection of BAL is a widely used 
technique that has been shown to accurately reflect cellular exudates from the lung 
parenchyma during lung injury [61]. Flow cytometry was used to measure the cellular 
and fluorescent characteristics of these cells after labeling with fluorochrome 
conjugated monoclonal antibodies and fixation. Cell populations were determined by 
their FSC/SSC profiles and the cell surface antigen expression of CD172a and 
CD203a was indicated by staining with two monoclonal antibodies anti-porcine 
SWC3-PE and anti-porcine SWC9-FITC, respectively. Alveolar macrophage were 
gated and analyzed for purity, which exceeded >95%, and for the expression 14 




 Our data indicated that chronic A. suum trickle infection induced changes in 
the cellular composition of the BAL. Infection increased the percentage of 
eosinophils present in the BAL 25-28% compared to 6-8% in uninfected pigs. This 
increase in the percentage of eosinophils was accompanied by a reciprocal decrease in 
the percentage of macrophages. In pigs given a primary single dose A. suum the level 
of eosinophilia is significantly higher than those observed in the current study with up 
to 70% eosinophils in the BAL at approximately two – three weeks after inoculation 
[52]. Since eosinophils are an indicator of inflammation and important for acquired 
immunity to parasitic infections, the relatively lower percentage of eosinophilia 
observed in this study could indicate an acquired immunity to chronic infection or a 
result of fewer migrating larvae in the lung following multiple exposures or a down 
regulatory effect induced by chronic infection. Several studies indicated an acquired 
immunity to A. suum after repeated exposure; however, the mechanism remains 
elusive [19, 62-63].  It is not clear which organ system is most prominent in the 
resistance to migrating A. suum larvae. Urban et al. (1988) reported a reduced “milk 
spot” formation in the liver following trickle infection that suggested a pre-hepatic 
immunity. However, Serrano et al (2000) observed a low number of larvae in the lung 
compared to the number of “milk spots” and suggesting this reflects the trapping of 
larvae in the liver and indicates a more pronounced immunity in the lung. A recent 
study using green fluorescent IL-4 reported mice and truncated larval infection 
identified the lung as an important site for priming CD4 T-cell-mediated protective 
immunity against N. brasiliensis, a gastrointestinal nematode parasite of rodents that 




future interest to identify if the acquired protection of pigs to A. suum infection in the 
lungs expresses a similar mechanism. A greater understanding of the key 
immunological processes that lead to the development of acquired immunity could 
lead to new vaccine strategies that contribute to improved human and animal health.   
  One objective of this study was to determine if ATRA and/or long-term 
exposure to A. suum altered AM expression of CD206. The mannose receptor 
(CD206) is a type 1 trans membrane glycoprotein expressed by macrophages and 
certain populations of endothelial and dendritic cells. CD206 expression on 
macrophages has become a well know marker of macrophage alternative activation 
[34]. Tissue resident AM are known to constitutively expression CD206 indicating 
these cells are already polarized to an alternatively activated macrophage (AAM) 
phenotype. A study in humans with lung fibrosis showed an up-regulation CD206 in 
these patients when compared to normal control patients, indicating a highly 
polarized AAM phenotype [65]. Since, A. suum larval migration induces extensive 
lung damage and tissue fibrosis and is an inducer of Th2-type immune responses in 
which it is believed AAM play a pivotal role, we investigated the effect of infection 
on AM CD206 expression [53-54]. In previous studies, (Dawson et al, unpublished) 
primary explanted AM stimulated in-vitro with ATRA demonstrated a highly 
polarized AAM phenotype characterized by an up-regulation of several cell surface 
markers associated with alternative activation as well as mRNA induction of several 
genes associated with alternative activation. In the current studies using freshly 
explanted cells isolated from BAL, no changes were seen in CD206 expression to an 




ATRA or to A. suum trickle infection. Interestingly, CD163 expression in AM of A. 
suum infected pigs was significantly up-regulated compared to corn oil treated 
uninfected controls. The percentage of cells expressing CD163 (~95%) remained the 
same for all groups; however the MFI greatly increased on cells from A. suum 
infected pigs. This may be of significance given that the up regulation of CD163 
expression is induced by IL-10, IL-6, and glucocorticoids, but down-regulated by IL-
4, IL-13, IFNγ, and TNFα [66]. CD163 expression appears to be tightly controlled by 
pro- and anti- inflammatory mediators, indicating that it may play an important role in 
the control of inflammation [67]. Macrophages with high CD163 expression have 
been identified during the resolution phase of inflammation, indicating a possible role 
in regulating tissue repair [57]. CD163 functions as a scavenger receptor that 
binds and internalizes circulating haptoglobin-hemoglobin (Hp–Hb) 
complexes. Internalization of these complexes then fuels an anti-inflammatory 
response via the secretion of IL-10 that is mediated by heme metabolites [67-
68].  Hemorrhage and  increasing red blood cell content in the alveolar 
spaces is a feature of the early response to migrating A. suum L3 in the lung 
that is rapidly resolved with time after infection. In our data, the high 
expression of CD163 on AM of A. suum trickle infected pigs may indicate a 
macrophage phenotype that differs from the AAMs reported during primary 
parasite exposure. The macrophages we observed may fit more into the 
category of regulatory macrophages (RM) or into a spectrum between AAM 
and RMs proposed by Mosser and Edwards (2008). Macrophages expressing 




AAM, however, data indicating that IL-4 and IL-13 down-regulate this 
molecule on macrophages goes against this theory. CD163 expressing 
macrophages have also been implicated as having an important role in 
wound repair processes; however RMs are thought to not be involved in this 
process. Given this contradiction, further investigation into the phenotype, 
function, and role of these cells during chronic A. suum infection seems 
warranted.  
 We also examined the expression of two other surface molecules 
associated with macrophage alternative activation, the IL-4 receptor and the 
triggering receptor expressed on myeloid cells 2 (TREM2). Only ATRA fed 
pigs had a higher MFI and higher percentage of macrophages expressing IL-
4R. It is important to note that two out of the three pigs examined had higher 
IL-4R expression whereas one pigs had expression levels comparable to 
controls pigs, therefore these data were not statistically significant. It is 
possible that ATRA was inefficiently administered to this pig or that it became 
oxidized, although the multiple exposures to ATRA make this unlikely. The 
out-bred genetic background of these animals could indicate a pig 
unresponsive to the dose of ATRA that was given.  TREM2 MFI expression 
was very low on control corn oil treated pigs but was found to be significantly 
up-regulated on ATRA fed pigs as well as infected pigs with the highest 
expression seen on ATRA treated pigs. Likewise the percentage of cells 
positive for TREM2 expression were highest on ATRA fed pigs (33%) and A. 




infection only treated pigs (5%). It has been proposed that VA deficiency shifts the 
immune response towards a Th1 cell mediated response whereas VA supplementation 
boosts a Th2 response [28]. In our study the pigs are not VA deficient, however given 
the observed up-regulation of these two surface molecules on pigs fed ATRA in the 
absence of infection it is possible that ATRA is acting on resident AM to induce a 
skewed Th2 immune response in pigs. Functional studies of these cells are lacking 
and further studies would have to be performed to verify this theory.  However, 
archived samples of isolated RNA could be used associate changes in gene expression 
with phenotype. TREM2 has been found to be up-regulated on macrophages exposed 
to IL-4 and IL-13 and on infiltrating macrophages independent of presence of 
alternative activation [60]. Since infiltrating macrophages express TREM2, this could 
provide one explanation for the observed TREM2 expression and lack of IL-4R 
expression on AM of infected pigs. Interestingly, infected pigs fed ATRA have a 
higher percentage of cells expressing TREM2 than pigs infected only.  It is possible 
that ATRA is having some effect on resident macrophages while infection is inducing 
the infiltration of TREM2 expressing macrophages. Again, further studies need to be 
performed to verify this theory.    
    The expression of the programmed death ligand 1 (CD274) was found to be 
constitutively expressed on AM of control pigs, however its expression was 
significantly increased in pigs from all the other treatment groups, with the highest 
expression on AM from pigs infected and treated with ATRA. The percentage of cells 
expressing CD274 was similar for all groups. CD274 is a member of the B7 family of 




its receptor, programmed death 1 (PD-1), on activated T-cells to down-regulate T cell 
responses [69]. Similar to our results, Siracusa et al [40] infected mice with N. 
brasiliensis and showed constitutive expression of CD274 by AM that significantly 
increased at 13 days post-infection. It was suggested that the expression of CD274 on 
AM indicated a more anti-inflammatory response during the later stages of infection. 
In our study, it is possible that CD274 expression on AM functions to suppress T-cell 
activity in order to avoid further inflammatory tissue damage during long-term 
exposure to A. suum that could be a target of immune regulation by ATRA.  Further 
research is necessary to determine if these cells are immunosuppressive.  
 We also investigated the expression of nine other surface molecules, CD25, 
CD29, CD39, CD62L, CD86, CD95, CD273, CD275, and CD279. Only two out of 
these nine, CD29 and CD39 were expressed by AM. CD29 was only expressed on 
cells from control corn oil treated uninfected pigs and ATRA fed pigs. Interestingly, 
CD29 was completely absent from AM from infected pigs regardless of ATRA 
treatment status. Our data did not indicate a role for ATRA in regulating CD29 
expression on AM; however infection may negatively regulate CD29 expression. 
CD29 is a part of the integrin family involved in immune cell trafficking from blood 
to tissues [70]. CD39 is an integral membrane protein with triphosphate 
diphosphohdrolase activity that converts ATP to AMP [70]. Only pigs fed ATRA in 
the absence of infection expressed CD39, whereas all other treatment groups did not.
 In conclusion, we observed marked changes in several surface molecules 
expressed by AM in response to A. suum trickle infection and/or feeding ATRA at a 




infection indicated a population of cells that express characteristics of both AAMs 
and RMs that suggested functional inhibition of T-cell responses and inflammation. 
Administration of ATRA in the absences of infection induced a population of AM 
that could potentially boost type-2 like immunity to pathogens. Given these results, 
further studies to define the dynamics and functional role of AM during A. suum 
infection and in response to feeding ATRA could model the health consequences in 
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